Related Experiment Video
Updated: Jul 21, 2026

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
Urinary volatile organic compounds in prostate cancer biopsy pathologic risk stratification using logistic regression
Sabur Badmos1, Elizabeth Noriega-Landa1, Kiana L Holbrook1
1Department of Chemistry and Biochemistry, University of Texas at El Paso El Paso, Texas, USA.
This study introduces a new method using urine volatile organic compounds (VOCs) to detect prostate cancer (PCa) and its grade. This approach offers a promising alternative to current screening methods, potentially reducing unnecessary biopsies.
Area of Science:
- Metabolomics
- Analytical Chemistry
- Computational Biology
Background:
- Prostate cancer (PCa) is a leading cause of cancer death in men.
- Current prostate-specific antigen (PSA) testing lacks specificity, leading to over-diagnosis and unnecessary biopsies.
- Novel diagnostic tools are needed for accurate PCa detection and grading.
Purpose of the Study:
- To explore the use of urinary volatile organic compounds (VOCs) for PCa diagnosis.
- To develop and evaluate machine learning models for PCa detection and grade assessment.
- To provide an alternative or adjunct to current PCa screening methods.
Main Methods:
- Urine samples from 386 men (247 with PCa, 139 controls) were analyzed.
- Volatile organic compounds (VOCs) were extracted using stir bar sorptive extraction (SBSE).
- Gas chromatography-mass spectrometry (GC-MS) and regularized logistic regression with machine learning were employed.
Main Results:
- A diagnostic model achieved an AUC of 0.99 (training) and 0.88 (testing).
- A model differentiating low-grade from intermediate/high-grade PCa achieved an average AUC of 0.78.
- Over 22,000 VOCs were identified in urine samples.
Conclusions:
- Urinary VOC analysis combined with machine learning shows high accuracy for PCa detection.
- This method can help differentiate PCa grades, aiding in biopsy targeting.
- This approach offers a promising non-invasive tool to improve PCa screening and management.
Related Concept Videos
Cancer Survival Analysis
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Urine Studies I: Urinalysis

